RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial

Table 2 Changes of Corneaconjunctival Staining Score (NEI score) between CN and DQ group

	0	4 weeks	12 weeks	Difference (0–4 weeks) ^a	Difference (0–12 weeks)^a	P value (0–12 weeks)^b
CN	10.78 ± 5.02 (4.00~27.00)	6.03 ± 3.67 (1.00~17.00)	4.17 ± 3.57 (0.00~16.00)	−4.74 ± 4.63 (−26.00~3.00)	−6.60 ± 4.47 (− 22.00~3.00)	< 0.0001
DQ	10.25 ± 4.89 (4.00~23.00)	6.21 ± 4.36 (1.00~24.00)	3.61 ± 3.45 (0.00~16.00)	−4.04 ± 4.12 (−17.00~3.00)	−6.63 ± 4.72 (− 18.00~7.00)	< 0.0001
P value	0.5220	0.9708	0.3214	0.4860	0.9739

CN 0.05% cyclosporin nanoemusion (0.5 mg/mL), DQ 3% diquafosol sodium (30 mg/mL)
^aComparison between CN and DQ groups by Wilcoxon rank sum test
^bComparison among three groups by Kruskal-Wallis test

ISSN: 1471-2415